Production (Stage)
Adaptimmune Therapeutics plc
ADAP
$0.2801
$0.00572.08%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -60.71% | -18.53% | -13.36% | 49.52% | -2.24% |
| Total Receivables | 30.47% | -58.61% | 62.48% | -17.75% | -38.42% |
| Inventory | 59.36% | 274.38% | 54.23% | -23.38% | 25.51% |
| Prepaid Expenses | -25.50% | -29.17% | 32.98% | 8.09% | -1.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.65% | -6.07% | 2.68% | 15.86% | 17.62% |
| Total Current Assets | -45.26% | -22.95% | -3.77% | 35.78% | -9.95% |
|
|
|||||
| Total Current Assets | -45.26% | -22.95% | -3.77% | 35.78% | -9.95% |
| Net Property, Plant & Equipment | -4.45% | -21.55% | 1.90% | -5.40% | -5.55% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -1.91% | -9.41% | 330.02% | 90.08% | 58.79% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -13.69% | -26.12% | 27.32% | 0.28% | -5.55% |
| Total Assets | -35.73% | -22.52% | -1.33% | 24.69% | -8.71% |
|
|
|||||
| Total Accounts Payable | -34.41% | -4.16% | 20.71% | 14.06% | -18.96% |
| Total Accrued Expenses | -28.10% | 1.85% | -1.32% | 37.18% | -22.33% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -1.74% | 12.79% | -21.12% | 0.82% | -2.49% |
| Total Finance Division Other Current Liabilities | -8.39% | 1.77% | -48.41% | 19.77% | 5.73% |
| Total Other Current Liabilities | -8.39% | 1.77% | -48.41% | 19.77% | 5.73% |
| Total Current Liabilities | -20.85% | 1.69% | -22.68% | 23.58% | -8.76% |
|
|
|||||
| Total Current Liabilities | -20.85% | 1.69% | -22.68% | 23.58% | -8.76% |
| Long-Term Debt | -49.42% | 0.75% | 99.83% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.09% | -5.83% | 19.61% | -7.27% | -7.10% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.26% | -3.46% | 2.34% | -31.91% | -1.12% |
| Total Liabilities | -16.49% | -1.40% | 5.33% | -3.51% | -3.89% |
|
|
|||||
| Common Stock & APIC | 0.07% | 0.26% | 0.28% | 0.28% | 3.03% |
| Retained Earnings | -4.35% | -7.28% | -1.76% | 6.49% | -4.74% |
| Treasury Stock & Other | -131.97% | 62.97% | -50.53% | -25.44% | 27.43% |
| Total Common Equity | -415.88% | -85.19% | -16.92% | 294.97% | -38.31% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -415.88% | -85.19% | -16.92% | 294.97% | -38.31% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -415.88% | -85.19% | -16.92% | 294.97% | -38.31% |
|
|
|||||